McGill University Faculty of Medicine - Royal Victoria Hospital

Montreal, Quebec H4A 3J1

0 studies enrolling now · 2 studies all time

What they study most

Advanced Epithelioid Sarcoma, Advanced Soft-tissue Sarcoma, Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment

Studies at this site

• Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma — Stopped early
• A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer — Stopped early